CytoSorbents (NASDAQ:CTSO) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
CytoSorbents missed estimated earnings by 75.0%, reporting an EPS of $-0.21 versus an estimate of $-0.12.
Revenue was up $700 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 7.46% drop in the share price the next day.
Here's a look at CytoSorbents's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.13 | -0.17 | -0.16 |
| EPS Actual | -0.14 | -0.17 | -0.01 | -0.28 |
| Revenue Estimate | 11.03M | 8.73M | 8.72M | 8.98M |
| Revenue Actual | 9.42M | 9.45M | 9.39M | 8.11M |
To track all earnings releases for CytoSorbents visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
